Identification of <i>LPCAT1</i> expression as a potential prognostic biomarker guiding treatment choice in acute myeloid leukemia.

Oncol Lett · 2021 · PMC7751346 · PMID 33376538

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Furthermore, Kaplan-Meier analysis also demonstrated that patients with higher expression levels of LPCAT1 exhibited significantly shorter OS time compared with those with lower expression of LPCAT1 among total-AML and non-M3 AML cases, whereas a trend for LFS time was observed which did not reach statistical significance ( Fig. 1A and B ).

also in 111,027 other papers

showed a trendno p-value reported

The results of Cox regression univariate analysis revealed that LPCAT1/2/3 expression was associated with OS in AML, and LPCAT3 expression was associated with LFS, whereas LPCAT1/2 expression showed a trend being associated with LFS ( Table I ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.